NCT06395532

Brief Summary

The integrated pulmonary index (IPI) is a newly developed index for respiratory monitoring. However, there is limited evidence on its effectiveness and usefulness in critically ill patients. The purpose of this study is to evaluate the clinical relevance of the IPI as a predictor of respiratory compromise in critically ill patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 2, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 16, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2024

Completed
Last Updated

May 2, 2024

Status Verified

April 1, 2024

Enrollment Period

6 months

First QC Date

April 23, 2024

Last Update Submit

April 30, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Respiratory Failure

    1. Hypoxia 2. Hypercapnia

    6 months

Secondary Outcomes (1)

  • Complications

    6 months

Study Arms (2)

Respiratory compromise (RC) group

Other: Observetional

Non respiratory compromise (RC) group

Other: Observetional

Interventions

After admission to the ICU, patients will be continuously monitored with ICU standard monitoring in addition to IPI using (Capnostream™ Medtronic). IPI will be recorded after transfer to the ICU, as well as at 2, 6, 12, 18 and 24 hours.

Non respiratory compromise (RC) groupRespiratory compromise (RC) group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Included patients will receive the standard care, according to the usual standard clinical practice at the institution. After admission to the ICU, patients will be continuously monitored with ICU standard monitoring in addition to IPI using (Capnostream™ Medtronic). IPI will be recorded after transfer to the ICU, as well as at 2, 6, 12, 18 and 24 hours. Any respiratory, hemodynamic events or interventions will be recorded by the ICU nurses who will be blinded for the study.Demographic ( age, gender, BMI, co morbidities), clinical, laboratory, and outcomes data will be obtained from the medical records. Routine laboratory tests were done for all patients, including CBC, C-reactive protein, renal profile, coagulation profile and liver profile.

You may qualify if:

  • Critically ill patients aged 18 years or older of both genders admitted to the intensive care unit

You may not qualify if:

  • Age \< 18 years' old
  • Morbid obesity
  • Mechanical ventilation
  • Hemodynamic instability.
  • Thoracotomy and cardiac surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 23, 2024

First Posted

May 2, 2024

Study Start

May 15, 2024

Primary Completion

November 16, 2024

Study Completion

December 22, 2024

Last Updated

May 2, 2024

Record last verified: 2024-04